Capital Guardian Trust’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-80,856
Closed -$6.48M 718
2016
Q4
$6.48M Sell
80,856
-15,100
-16% -$1.2M 0.05% 184
2016
Q3
$7.65M Sell
95,956
-15,525
-14% -$1.25M 0.06% 186
2016
Q2
$8.7M Sell
111,481
-193,523
-63% -$13.8M 0.07% 182
2016
Q1
$16.8M Sell
305,004
-854,357
-74% -$46.5M 0.13% 152
2015
Q4
$71.6M Sell
1,159,361
-261,503
-18% -$16.5M 0.56% 63
2015
Q3
$89.6M Sell
1,420,864
-27,814
-2% -$1.99M 0.73% 44
2015
Q2
$106M Sell
1,448,678
-15,455
-1% -$1.12M 0.76% 43
2015
Q1
$95.8M Sell
1,464,133
-309,240
-17% -$20.6M 0.71% 51
2014
Q4
$115M Buy
1,773,373
+817,555
+86% +$52.7M 0.8% 46
2014
Q3
$57.5M Buy
955,818
+604,918
+172% +$39.5M 0.41% 82
2014
Q2
$24.3M Buy
+350,900
New +$22.7M 0.17% 121

Other funds holding STJ

Capital Guardian Trust's STJ Position: Q1 2017 in Review

Capital Guardian Trust sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 80,856 shares — an estimated $6.48M sold.

Capital Guardian Trust first reported a position in STJ in Q2 2014 and held it in 11 quarters. The position peaked at $115M in Q4 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Capital Guardian Trust reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Capital Guardian Trust sold 80,856 St Jude Medical shares in Q1 2017, an estimated $6.48M.
  • Capital Guardian Trust first reported a position in St Jude Medical in Q2 2014 and held it in 11 quarters.
  • Capital Guardian Trust's St Jude Medical position peaked at $115M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Capital Guardian Trust's 13F filing for Q1 2017, filed 15 May 2017.